Alnylam Pharmaceuticals, Inc. (BMV:ALNY)

Alnylam Pharmaceuticals Ratios and Metrics

Market cap in millions MXN. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 29, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,092,529	632,425	406,090	570,313	415,790	300,466
Market Cap Growth	42.80%	55.73%	-28.79%	37.16%	38.38%	24.07%
Enterprise Value	1,090,364	631,299	410,448	576,677	407,412	291,285
Last Close Price	8380.00	4900.00	3227.45	4682.29	3880.27	2750.00
PS Ratio	23.53	13.50	13.14	28.18	24.02	30.64
PB Ratio	231.19	452.40	-108.87	-184.79	34.48	14.86
P/TBV Ratio	231.19	452.40	-	-	34.48	14.86
P/FCF Ratio	-	-	572.67	-	-	-
P/OCF Ratio	-	-	230.62	-	-	-
EV/Sales Ratio	24.10	13.48	13.28	28.50	23.54	29.70
EV/FCF Ratio	-1110.03	-	578.81	-	-	-
Debt / Equity Ratio	10.93	40.89	-12.16	-16.51	3.72	1.57
Debt / FCF Ratio	-	-	63.96	-	-	-
Asset Turnover	0.57	0.56	0.50	0.29	0.24	0.17
Inventory Turnover	5.17	3.86	2.85	1.57	1.74	1.19
Quick Ratio	2.63	2.61	2.86	3.17	3.79	4.23
Current Ratio	2.80	2.78	3.08	3.51	4.04	4.47
Return on Equity (ROE)	-257.82%	-	-	-526.14%	-106.31%	-69.92%
Return on Assets (ROA)	-2.63%	-2.74%	-4.78%	-13.65%	-12.56%	-17.85%
Return on Capital (ROIC)	-3.95%	-4.19%	-7.17%	-18.77%	-16.46%	-23.80%
Earnings Yield	-0.55%	-0.92%	-1.83%	-3.87%	-4.21%	-5.68%
FCF Yield	-0.09%	-0.14%	0.18%	-2.10%	-3.54%	-4.54%
Buyback Yield / Dilution	-2.84%	-2.20%	-2.64%	-2.73%	-3.01%	-5.24%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.